References
- Sagalowsky AI, Wilson JD. Carcinoma of the prostate. In: Petersdorf RG, Adams RD, Braunwald E, et al, eds. Harrisons principles of internal medicine. 10th ed. New York: McGraw-Hill, 1983: 795–7
- Baum NH, Brown PS. Medical management of advanced prostate cancer. Presented at Touro Infirmary. New Orleans: 1990 Mar
- Carter HB, Isaacs JT. Experimental and theoretical basis for hormonal treatment of prostatic cancer. Semin Urol 1988: 6(4): 262–8
- Catalona WJ, Scott WW. Carcinoma of the prostate. In: Walsh PC, Gittes RF, Perlmutter AD, et al, eds. Campbell's urology. Philadelphia: WB Saunders, 1986: 1463–1520
- Carroll PR, Narayan P. Treatment options for hormone-insensitive or independent prostatic carcinoma. Semin Urol 1988: 6(4): 322–35
- Salmon SE. Malignant disorders. In: Schroeder SA, Krupp MA, Tierney LM, eds. Current medical diagnosis and treatment: 1988. East Norwalk, CT: Appleton & Lange, 1988: 1061–7
- Brendler CB. Prostate-specific antigen: significance in evaluation of men with prostate cancer. Adv Urol 1989: 2: 1–24
- Wajsman Z, Klimberg IW. Staging evaluation and follow-up of patients with advanced prostatic cancer. Semin Urol 1988: 6(4): 249–61
- Stamey TA. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Monogr Urol 1989: 10(4): 50–63
- Maatman TJ, Gupta MK, Montie JE. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate. J Urol 1985: 133(4): 620–1
- Susan LP, Roth RB, Adkins WC. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate. Urology 1976: 7(6): 598–601
- Veterans Administration Cooperative Urological Research Group. Carcinoma of the prostate: treatment comparisons. J Urol 1967: 98(4): 516–22
- Sandow J, Beier B. LHRH agonists: mechanism of action and effect on target tissues. Prog Clin Biol Res 1985: 185A: 121–42
- Trachtenberg J. Ketoconazole therapy in advanced prostatic cancer. J Urol 1984: 132(1): 61–3
- Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989: 321(7): 419–24 [erratum, N Engl J Med 1989: 321(20): 1420]
- Labasky RF, Smith JA Jr. Management of pain and other symptoms of advanced prostatic cancer. Semin Urol 1988: 6(4): 311–21
- Johnson DE, Babaian RJ, von Eschenbach AC, et al. Ketoconazole therapy for hormonally refractive metastatic prostate cancer. Urology 1988: 31(2): 132–4
- Sause WT. The role of radiation therapy in the management of advanced prostate cancer. Semin Urol 1988: 6(4): 279–90
- Kuban DA, Delbridge T, el-Mahdi AM, et al. Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate. J Urol 1989: 141(3): 572–4
- Surya BY Provet JA. Manifestations of advanced prostate cancer: prognosis and treatment. J Urol 1989: 142(4): 921–8
- Kuban DA, el-Mahdi AM, Sigfred SV, et al. Characteristics of spinal cord compression in adenocarcinoma of prostate. Urology 1986: 28(5): 364–9
- Lowe FC, Somers WJ. The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer. J Urol 1987: 137(5): 1000–2